One minor correction. SSC guidelines are based on published literature, and the data analysis for our recent publication were locked nearly a year before the publication of TIGRIS. The guidelines were released one or two days before TIGRIS results were, both at the recent SCCM Congress. I won't hazard a guess at how the guideline committee would have dealt with these data, but "ample access" to the data is off the mark.
Thanks! I think our manuscript had to be submitted to the various contributing societies in early September, if I remember correctly. It takes a long time to get society buy-in and then journal review.
Excellent points dubious effect for sure - why does Europe allow? Thought we and our system of too much spending for worse results at least had the “benefit” of a safe haven for medical innovation - pt harm be less of a concern.
One minor correction. SSC guidelines are based on published literature, and the data analysis for our recent publication were locked nearly a year before the publication of TIGRIS. The guidelines were released one or two days before TIGRIS results were, both at the recent SCCM Congress. I won't hazard a guess at how the guideline committee would have dealt with these data, but "ample access" to the data is off the mark.
Thank you. This error has been corrected. I do note that the Tigris data was released in October 2025, but not published as you note.
Thanks! I think our manuscript had to be submitted to the various contributing societies in early September, if I remember correctly. It takes a long time to get society buy-in and then journal review.
Excellent points dubious effect for sure - why does Europe allow? Thought we and our system of too much spending for worse results at least had the “benefit” of a safe haven for medical innovation - pt harm be less of a concern.